Humanized monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
US10570215B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2017 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Mar 19, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/01003
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a humanized monoclonal antibody or an antibody fragment thereof that selectively inhibits the enzymatic activity of vascular endothelial lipase and pharmaceutical compositions containing the same as an active ingredient useful for the treatment of arteriosclerosis or metabolic syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.